Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis

Digestive Diseases and Sciences

Volumn 46, Issue 11, 2001, Pages 2408-2414

  Kubo, Shoji ^a   Tamori, Akihiro ^a   Ohba, Kazuki ^a   Shuto, Taichi ^a   Yamamoto, Takatsugu ^a   Tanaka, Hiromu ^a   Nishiguchi, Shuhei ^a   Wakasa, Kenichi ^b   Hirohashi, Kazuhiro ^a   Kinoshita, Hiroaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatic fibrosis; Hepatitis B virus; Hepatitis B x DNA; Hepatitis B x RNA; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

HEPATITIS B ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VIRUS GENE;

AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, VIRAL;

EID: 0034765716     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012359400193     Document Type: Article

References (50)

1. Viruses and hepatocellular carcinoma
2. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH 3T3 cells
3. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA
4. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
5. Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver
6. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan
7. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection
8. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen
9. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B
10. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B
11. Hepatitis B virus persistence after recovery from acute viral hepatitis
12. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response
13. Polymerase chain reaction to direct hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen
14. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma
15. Viral pathogenesis of hepatocellular carcinoma in the United States
16. Significance of hepatitis B and hepatitis C viral sequences frequently detected in hepatocellular carcinoma tissues
17. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma
18. Hepatitis C and B virus infections in hepatocellular carcinoma: Analysis of direct detection of viral genome in paraffin embedded tissues
19. Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients
20. High prevalence of hepatitis B and C viruses in patients with hepatocellular carcinoma in Japan
21. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease
22. Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan
23. Hepatitis C virus associated primary hepatocellular carcinoma in a noncirrhotic liver
24. HCV-associated liver cancer without cirrhosis
25. HCV-associated hepatocellular carcinoma without cirrhosis
26. Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus
27. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma
28. Development of hepatocellular carcinoma in patients with hepatitis C virus infection, with or without past hepatitis B virus infection, and relationship to age at the time of blood transfusion
29. Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis
30. The role of previous infection of hepatitis B virus in HBs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: Etiological and molecular biological study
31. Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma
32. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies
33. Formulation on application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
34. Classification of chronic hepatitis: Diagnosis, grading and staging
35. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
36. Cloning and structural analyses of hepatitis B virus DNAs, subtype adr
37. Primary liver cancer in Japan: Clinicopathologic features and results of surgical treatment
38. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: Comparison in patients with hepatitis B virus and hepatitic C virus-associated cirrhosis
39. Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis
40. Ornithine decarboxylase activity in the noncancerous hepatic tissue of patients with hepatocellular carcinoma
41. Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C
42. Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues
43. Hepatitis B X antigen in hepatitis B virus carrier patients with liver cancer
44. Integrity of p53 in hepatitis B X antigen-positive and -negative hepatocellular carcinomas
45. Hepatitis B X antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma
46. Functional inactivation but not structural mutation of p53 causes liver cancer
47. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
48. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
49. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan